DOvEE

There has been no improvement in the cure rate of ovarian cancer in 30 years and this is unacceptable. If you look at a cell phone or computer from 30 years ago, today’s versions are tremendously different, and these types of advancements need to happen with respect to the early diagnosis of ovarian cancer.

Dr. Lucy Gilbert

Founder of the DOvEE project and Head of Gynecologic Oncology, MUHC

The Challenge

This year alone, 7,300 and 2,800 Canadian women will be diagnosed with endometrial and ovarian cancers respectively. Together, they are the third leading causes of cancer-related death in North American women. Ovarian cancer in particular is often called the silent killer because it can mimic other ailments until it is far too late. The good news is survival rates reach 80% when diagnosed in phase I and II. Sadly, 75% of ovarian cancers are diagnosed in phases III and IV, when the cancer has spread. Although early detection holds the key to improving survival rates for ovarian and endometrial cancers, there are currently no reliable screening tests to diagnose these two deadly types of cancers at their earliest possible stage.

The solution

The McGill University Health Centre’s (MUHC) Detecting Ovarian and Endometrial Cancer Early (DOvEE) project is the only one of its kind in the world.

Founded by Dr. Lucy Gilbert, she and her team of medical professionals are working to stop ovarian and endometrial cancers in their tracks by increasing the awareness of symptoms through satellite testing clinics around Montreal and offering free fast-tracked diagnostic testing to symptomatic women without a doctor’s referral.

Dr. Gilbert and her team have also pushed the early screening of ovarian and endometrial cancers one step further by developing a test that provides a safe and minimally invasive method to detect ovarian and endometrial cancers at an earlier stage than currently possible with existing tests, with the potential to increase survival rates.

In order for the DOvEE project to push the limits what’s possible, they must:

  • Continue to refine this novel and reliable screening test that will revolutionize the detection of ovarian and endometrial cancers, catching them at their earliest possible stages and improving survival rates
  • Conduct innovative research and clinical trials to better understand how ovarian and endometrial cancers start, grow, and spread
  • Make the new kit developed by the DOvEE team standard of care

How you can help

To allow Dr. Gilbert to apply for an available public grant, the MUHC Foundation has launched a $2 million Campaign. With this support, Dr. Gilbert and her team will conduct the necessary validation phase to get the DOvEEgene test approved as standard of care. The test will first be offered to Montreal women as part of the validation phase. Once approved, this test could be available throughout the world in GPs or Gynecologist offices saving millions of lives by diagnosing ovarian and endometrial cancers early, when they are most treatable.

For more information, to make a donation or to get involved, please contact Edith Bolduc, Development Officer, Major Gifts, 514-934-1934, ext. 34397, edith.bolduc@muhc.mcgill.ca

You can donate online, download our donation form or call us at 514-843-1543.

To make a gift in shares or mutual funds, please download this form.

DOvEE Campaign Co-chairs

DOvEE Campaign Co-chairs, from left: Micol Haimson, Matthew Marchand and Joanne Photiades

Joining us on this campaign are committee members:

  • Micol Haimson, Co-chair
  • Matthew Marchand, Co-chair
  • Joanne Photiades, Co-chair
  • Valerie Aitken
  • Pam Brydges
  • Shellie Feldman
  • Bonnie Fletcher
  • Justine Frangouli-Argyris
  • Paula Gillett
  • Catherine Heaton
  • Anne Lafleur
  • Houda Moussalier
  • Marissa Nuss

Follow Us

Notre équipe est ravie d’annoncer la nomination de Jane Craighead et Michael Denham à titre de vice-présidents du conseil d’administration de la Fondation du CUSM. Ils siègeront aux côtés des vice-présidents déjà en poste, Marc Tellier, Partenaire McKinsey & Compagnie, et Claire Trottier, PhD. Michael Denham est président et chef de la direction de la BDC. Jane Craighead, PhD., CPA, CA, était vice-présidente principale des ressources humaines mondiales à la Banque Scotia avant sa retraite en 2019.

Le président du conseil d’administration, Norman Steinberg, Ad. E., a été confirmé comme président pour un second mandat de deux ans!

🔹🔹🔹

Our team is pleased to announce the appointment of Jane Craighead and Michael Denham as Vice-Chairs of the Board of Directors of the MUHC Foundation. They will join current Vice-Chairs Marc Tellier, Partner at McKinsey & Company, and Claire Trottier Ph.D. Michael Denham is President and CEO of BDC. Jane Craighead, Ph.D., CPA, CA, was a Senior Vice President in Global Human Resources at Scotiabank prior to her retirement in 2019.

Chair of the Board Norman Steinberg, Ad. E. will also be renewing his seat as chair for a second two-year mandate!
... See MoreSee Less

View on Facebook

À qui la chance! 👏🏌️‍♀️ Merci Fondation Yvon Michel! ... See MoreSee Less

View on Facebook

Soutenir dans tous les sens! La Fondation de CUSM veut remercier l’équipe de Kanuk, qui s’est donné pour mission de soutenir la population durant cette pandémie. Au cœur de la crise, leurs ateliers montréalais ont répondu au besoin d'urgence des hôpitaux en confectionnant des jaquettes de protection. 👏 Ils ont également fait un don de 22 500 $ à la Fondation du CUSM de la part de leur équipe, de leurs clients et de leur communauté, grâce aux revenus générés par la vente de leurs masques. Merci Kanuk pour votre leadership!
---
During the peak of the pandemic, the Kanuk team and their Montreal workshops responded to the urgent need of local hospitals by making protective gowns. 👏 They also made a donation of $22,500 to the MUHC Foundation on behalf of their team, as well as their clients and community, thanks to revenue generated from the sale of their face masks. Thank you Kanuk for your leadership!
... See MoreSee Less

View on Facebook

Alert level orange: what does it mean for Montrealers? Infectious disease specialist at Centre universitaire de santé McGill - McGill University Health Centre Dr. Don Vinh joined CTV Montreal to explore the latest COVID developments in Quebec. Watch full interview: bit.ly/33UBzee ... See MoreSee Less

View on Facebook